Medirom Healthcare Technologies Inc. (MRM) Current Deferred Revenue (2019 - 2025)
Medirom Healthcare Technologies (MRM) posted quarterly Current Deferred Revenue of $145160.9 for Q2 2025, down 71.15% year-over-year from $503119.8 in Q2 2024, and down 58.74% quarter-over-quarter from $351812.3 in Q4 2024.
Medirom Healthcare Technologies Inc. (MRM) Current Deferred Revenue (2019 - 2025) Analysis & Trends
Medirom Healthcare Technologies' Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $145160.9 for Q2 2025.
- In Q2 2025, Current Deferred Revenue fell 71.15% year-over-year to $145160.9; the TTM figure through Jun 2025 stood at $145160.9 (down 71.15% YoY), while the FY2024 annual figure was $351812.3, down 54.89% from the prior year.
- Current Deferred Revenue for Q2 2025 stood at $145160.9, down from $351812.3 in the prior quarter.
- The five-year high for Current Deferred Revenue was $2.7 million in Q2 2021, with the low at $145160.9 in Q2 2025.
- The 5-year median for Current Deferred Revenue is $739487.3 (2023), against an average of $837272.5.
- The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue sank 72.42% in 2022, then advanced 17.37% in 2023.
- Medirom Healthcare Technologies' Current Deferred Revenue stood at $916515.7 in 2021, then plunged by 31.26% to $630027.0 in 2022, then grew by 17.37% to $739487.3 in 2023, then sank by 52.42% to $351812.3 in 2024, then tumbled by 58.74% to $145160.9 in 2025.
- Business Quant data shows MRM's Current Deferred Revenue at $145160.9 in Q2 2025, $351812.3 in Q4 2024, and $503119.8 in Q2 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 145,160.87 |
| Dec 31, 2024 | 351,812.28 |
| Jun 30, 2024 | 503,119.81 |
| Dec 31, 2023 | 739,487.29 |
| Jun 30, 2023 | 781,835.93 |
| Dec 31, 2022 | 630,026.98 |
| Jun 30, 2022 | 749,615.98 |
| Dec 31, 2021 | 916,515.74 |
| Jun 30, 2021 | 2.72 Mn |
| Dec 31, 2020 | 1.65 Mn |
| Dec 31, 2019 | 4.45 Mn |